Hamilton Wealth, LLC Novo Nordisk A S Transaction History

Hamilton Wealth, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$45.38 - $71.7 $2.41 Million - $3.8 Million	-52,998 Closed	0 $0
Q2 2025 Nov 14, 2025	BUY	$58.08 - $81.05 $2.88 Million - $4.02 Million	49,565 Added 1443.78%	52,998 $3.66 Million
Q1 2025 Nov 14, 2025	SELL	$69.3 - $90.95 $6.6 Million - $8.66 Million	-95,194 Reduced 96.52%	3,433 $238,000
Q4 2024 Nov 14, 2025	BUY	$85.0 - $120.04 $6.75 Million - $9.54 Million	79,470 Added 414.84%	98,627 $8.48 Million
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $2.52 Million - $3.07 Million	-21,126 Reduced 52.44%	19,157 $2.28 Million

Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $2.89 Million - $3.46 Million	-23,573 Reduced 36.92%	40,283 $5.75 Million
Q1 2024 Jun 10, 2024	BUY	$102.11 - $135.92 $3.31 Million - $4.4 Million	32,382 Added 102.88%	63,856 $8.2 Million
Q4 2023 Feb 12, 2024	BUY	$87.78 - $105.45 $2.56 Million - $3.07 Million	29,148 Added 1253.14%	31,474 $3.26 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $211,526 - $464,130	2,326 New	2,326 $211,000

1,693

303M

25.9M

43.8M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Hamilton Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Wealth, LLC with notifications on news.